Rather than rely on FDA approval, EllieMD appears to substantiate its health claims by listing five scientific sources about halfway down the drops product page: However, four of the five sources listed are about the same study the actual study, an article on the study, a summary of the study and a paper about the subgroups of people that were involved in the study
These new analyses build on the growing body of clinical evidence for semaglutide, an important medicine that has already been extensively studied not only in obesity but also in cardiovascular disease and metabolic dysfunction-associated steatohepatitis (MASH), says Andrea Traina, PharmD, senior medical director, obesity and liver health, Novo Nordisk, in a release
Importantly, a distinct fungal signature has been identified that differentiates MASLD from ALD, highlighting the disease-specific nature of mycobiota dysbiosis 53
Axelsson et al
Its essential to discuss risk and benefits with your healthcare provider and to be aware of the potential side effect in order to manage them effectively: Nausea and vomiting : These are the most common side effects and usually decrease over time